Comparison between clinical and biochemical versus interleukin 28B as a predictive factor of virological response to direct antiviral drugs without interferone in treatment of hepatitis C virus patients
Last updated: 03 Jan 2025
10.21608/ejhm.2018.20458
HCV-direct acting antiviral drugs, interleukin 28b SNP
Mahmoud Mohammad Moussa
Bazeed
Department of Internal Medicine, Faculty of Medicine, Al-Azhar University
Anwar Gomaa
Elsheety
Department of Internal Medicine, Faculty of Medicine, Al-Azhar University
Mohammad Saied
Bakeer
Department of Internal Medicine, Faculty of Medicine, Al-Azhar University
Mohamed Ali
Saber
Department of Internal Medicine, Faculty of Medicine, Al-Azhar University
Essam Abdel Nabi
Mohammady
Department of Internal Medicine, Faculty of Medicine, Al-Azhar University
tantawy_wael@yahoo.com
73
10
4006
2018-10-01
2018-12-04
2018-10-01
7,842
7,849
1687-2002
2090-7125
https://ejhm.journals.ekb.eg/article_20458.html
https://ejhm.journals.ekb.eg/service?article_code=20458
30
Original Article
606
Journal
The Egyptian Journal of Hospital Medicine
https://ejhm.journals.ekb.eg/
Comparison between clinical and biochemical versus interleukin 28B as a predictive factor of virological response to direct antiviral drugs without interferone in treatment of hepatitis C virus patients
Details
Type
Article
Created At
22 Jan 2023